American BioScience, Inc. And American Pharmaceutical Partners To Present Six Abstracts On Applications Of Nanoparticle Albumin Bound (nab(TM)) Tumor Targeting Technology At The 97th American Association for Cancer Research Annual Meeting

Published: Apr 05, 2006

American Pharmaceutical Partners, Inc. (NASDAQ:APPX - News) and American Bioscience Inc. (ABI) today announced the presentation of data at the 97th Annual Meeting of the American Association of Cancer Research (AACR) that further highlights its proprietary nanoparticle albumin-bound (nab(TM)) tumor-targeting technology.

Back to news